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Emulsion technologies for multicellular tumour
spheroid radiation assays†
Kay S. McMillan,a Anthony G. McCluskey,b Annette Sorensen,b Marie Boydb and
Michele Zagnoni*a
A major limitation with current in vitro technologies for testing anti-cancer therapies at the pre-clinical
level is the use of 2D cell culture models which provide a poor reﬂection of the tumour physiology in
vivo. Three dimensional cell culture models, such as the multicellular spheroid, provide instead a more
accurate representation. However, existing spheroid-based assessment methods are generally labour-
intensive and low-throughput. Emulsion based technologies oﬀer enhanced mechanical stability during
multicellular tumour spheroid formation and culture and are scalable to enable higher-throughput assays.
The aim of this study was to investigate the characteristics of emulsion-based techniques for the for-
mation and long term culture of multicellular UVW glioma cancer spheroids and apply these ﬁndings to
assess the cytotoxic eﬀect of radiation on spheroids. Our results showed that spheroids formed within
emulsions had similar morphological and growth characteristics to those formed using traditional
methods. Furthermore, we have identiﬁed the eﬀects produced on the proliferative state of the spheroids
due to the compartmentalised nature of the emulsions and applied this for mimicking tumour growth and
tumour quiescence. Finally, proof of concept results are shown to demonstrate the scalability potential of
the technology for developing high-throughput screening assays.
1. Introduction
It has been estimated that approximately 50% of cancer
patients will receive radiotherapy as part of their treatment.1,2
Although radiotherapy delivers high success rates in certain
types of cancer, improvements are still required in others,
such as glioblastoma, where the chance of treatment failure
remains high.2 Physiologically relevant in vitro models at the
preclinical stage can play a significant role in improving the
eﬃcacy of radiotherapy.3 Current models are typically based
on cancer cell monolayers which provide an inadequate reflec-
tion of the tumour microenvironment in vivo4 due to a lack of
variations in cell proliferative state, cell-to-cell and cell-to-
matrix interactions and provide an unrealistic uniformity in
access to nutrients and oxygen by cells. In contrast, tumour
cells grown as 3D multicellular spheroids are more representa-
tive of in vivo tumour growth.5
Within a tumour, cells that are more distant from the blood
vessels become progressively quiescent (a reversible cell state
where cells are frozen in the G0–G1 phase of the cell cycle),
hypoxic and eventually necrotic.6,7 Utilisation of multicellular
tumour spheroids of ≥200 μm in diameter enables modelling
of blood vessel-free regions of tumours in vivo, mimicking the
diﬀusional limits of molecules created by the close packing of
cells within the 3D aggregate. This ultimately results in gradi-
ents of oxygen, glucose, lactate and pH from the external layer
of the spheroid down to its core.8 As a consequence, the outer
cellular layers of a spheroid are composed of proliferating
cells, whilst their inner layers present a quiescent phenotype
and, for spheroid of diameters typically greater than 400 μm, a
core containing hypoxic, apoptotic and necrotic cells.8,9 There-
fore, multicellular tumour spheroids represent a simplified
but physiologically relevant in vitro model for radiotherapy
development, also enabling the aspects of tumour heterogen-
eity and repopulation to be addressed.
Quiescent/hypoxic tumour cells have been shown to exhibit
increased resistance to radiation and chemotherapy drugs.10
This aspect is considered multifactorial but includes increased
activation of DNA repair machinery and alterations in apopto-
tic pathways which limits therapy and lethal damage.5 There-
fore, while radiotherapy and/or chemotherapy have toxic
eﬀects on rapidly proliferating cells, the more therapy-resistant
quiescent cells (within the tumour’s inner layers) can enter
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into the actively dividing phase of the cell cycle after treatment,
once renewed access to nutrients is obtained. This is a leading
cause of tumour relapse. Consequently, the use of multicellular
spheroids is expected to have an impact on developing more
eﬀective anticancer treatments as well as ‘bridge the gap’ between
physiologically relevant in vitromodels and animal models.11
Methods which have been traditionally used to form multicel-
lular spheroids include forced floating, hanging drop, agitation
based approaches (e.g. spinner flask) or via the incorporation of a
matrix or scaﬀold.4,12,13 However, while these methods are used
as standard in research labs, they are generally labour intensive,
present low-medium throughput and typically produce spheroids
of heterogeneous sizes.4 Therefore, novel methodologies are
desirable which avoid and/or minimise these drawbacks, allow-
ing 3D tumour models to be more widely adopted.
Emulsion-based technologies are becoming popular tools
for the formation and culturing of multicellular spheroids and
organoids.14–20 Such methods involve the encapsulation of cell
aggregates or cell suspensions within aqueous or gel (i.e.
agarose or alginate) droplets surrounded by a biocompatible
and non-adherent oil-surfactant interface (i.e. using fluori-
nated polyethyl glycol (PEG) block-copolymers21–23). One of the
attractive features of such systems is compartmentalisation, a
concept where each emulsion acts as a closed vessel carrying
out an environmentally isolated experiment.24 In contrast to
spinner flask techniques, where a cell suspension must be kept
in continuous motion to prevent cell attachment to the surface
of the flask,4 cells encapsulated either into a resting droplet or
an emulsion are not exposed to a shear stress, as it has been
demonstrated that shear forces can hinder cell physiology,
potentially impacting the eﬀect of a treatment.25 However, when
using hanging plates, exchange of medium or plate tilting can
result in merging and/or detachment of hanging droplets.26
Overall, these factors have an eﬀect on long term culture and
hinder the development of higher-throughput systems.
In this study, we have investigated the potential of emul-
sion-based techniques for the formation and long term culture
of multicellular cancer spheroids and their use for interrogat-
ing radiation toxicity as a proof of concept using either mostly
proliferative or mostly quiescent spheroids, the latter providing
a model for studying quiescent tumours. Using a human
glioma cell line (UVW), we have characterised the growth rates
of spheroids of variable size, their phenotypic features and
their response to X-ray irradiation depending on the emulsion
parameters. Results were compared to those achieved with
spheroids formed in spinner flasks and then seeded onto low
attachment plates. Finally, preliminary data is provided that
demonstrate the potential for the miniaturisation of such a
system in a high-throughput microfluidic format.
2. Experimental
2.1. Device preparation
Devices for both manual and microfluidic experiments were
fabricated using polydimethylsiloxane (PDMS) using standard
soft- and photo-lithography techniques. For manual experi-
ments, devices consisted of a 5 mm thick layer of PDMS (Dow
Corning Sylgard 184) containing open wells bonded to a micro-
scope slide. First, a silicon wafer was silanised by vapour depo-
sition of 1H,1H,2H,2H-perfluorooctyl-trichlorosilane (Sigma
Aldrich, UK) for 1 hour. Then, PDMS was poured onto the
wafer at a 10 : 1 ratio of base to curing agent, degassed in a
vacuum desiccator chamber and cured at 80 °C for a
minimum of 2 hours. A PDMS layer was then cut from the
mould and 20 wells of 8 mm in diameter were punched
through the layer using a biopsy punch. Subsequently, a PDMS
film (10 : 1 ratio of base to curing agent) of approximately
100 μm was spin-coated over a glass slide and the punched
PDMS layer was assembled on the fresh PDMS film. The struc-
ture was cured at 80 °C for an hour before use.
For microfluidic experiments, master templates were pro-
duced using SU8 photoresist (3000 series, MicroChem, US)
onto a silicon wafer following the manufacturer’s protocol,
achieving a final resist thickness of 200 μm. The resist was
exposed through a photomask (JD Photo-Tools, UK) to UV
light and was developed in MicroPosit EC solvent (Rohm and
Haas, US). To prevent PDMS adhesion to the resulting silicon
master, the silicon surface was silanised by vapour deposition
of 1H,1H,2H,2H-perfluorooctyl-trichlorosilane (Sigma Aldrich,
UK) for 1 hour. PDMS was then poured onto the silicon master
at a 10 : 1 ratio of base to curing agent, degassed in a vacuum
desiccator chamber and cured at 80 °C for 2 hours. The PDMS
devices were then peeled from the mould, cut to the desired
size, and holes were punched using G21 biopsy needles to
obtain the inlet and outlet wells for each chamber. PDMS
devices were then cleaned and irreversibly bonded to glass
microscope slides using oxygen plasma. Bonded devices were
then treated with undiluted Aquapel (PPG Industries) to
obtain fluorophilic channel surfaces.
2.2. Cell culture and spheroid formation
A human glioblastoma cell line (UVW) which was developed in
house was utilised.27 UVW cells were maintained in an atmos-
phere of 5% CO2 and incubated at 37 °C, in minimum essen-
tial medium (MEM), containing 10% (v/v) of foetal calf serum
(FCS), L-glutamine (200 mmol l−1), penicillin/streptomycin
(100 U ml−1) and fungizone (2 µg ml−1). Medium and
additional supplements were purchased from Invitrogen, UK.
To form spheroids within medium in oil (M/O) droplets in
open-well devices, 60 μl of FC-40 (3 M) fluorinated oil with
2 wt% block copolymer fluorosurfactants (designed by the
Weitz Group at Harvard and supplied by RAN Biotechnologies,
catalogue# 008-FluoroSurfactant, Beverly, MA, USA) was added
to each well. Subsequently, a cell suspension ranging 40–104
cells per ml was manually pipetted into the wells in droplet
volumes of 25–100 μl of medium depending on the experi-
mental purpose. For experiments interrogating the eﬀect of
irradiation on spheroids, droplets of 100 μl were used and the
medium was refreshed every two days (for a maximum of
28 days) by exchanging 50 μl in each droplet using a pipette.
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As a comparison, spheroids were also formed using the
conventional method of preparation in magnetic spinner
flasks, by seeding 1 × 106 cells into 75 ml of medium and then
incubating, on a magnetic stirrer, at an atmosphere of 5% CO2
at 37 °C for 3 days. Spheroids were then manually selected and
individually transferred into wells of a 96 well low attachment
plate using a Gilson pipette (Corning Costar) and incubated
for up to 28 days, with each well containing 200 μl of medium
which was refreshed every 2 days.
Finally, to investigate the miniaturisation and high-
throughput scalability of emulsion-based assays for multicellu-
lar spheroid culture, microfluidic devices were used. M/O dro-
plets (∼7 nl), encapsulating a UVW cell suspension, were
formed at a T-junction and stored within a device containing
an array of approximately 2000 droplets. FC-40 (3 M) fluori-
nated oil with 2 wt% block copolymer and a cell suspension (5
× 106 cells per ml in medium) were used as the continuous
and dispersed phases, respectively. PTFE (polytetrafluoroethy-
lene) tubing (Cole Parmer) were used to connect syringes to
the inlet ports of the microfluidic device (the microchannel
topology was based on a previously reported design28) and
syringe pumps were used to inject the phases. In this instance,
medium was not refreshed and devices were incubated after
seeding at an atmosphere of 5% CO2 and at 37 °C.
2.3. Spheroid growth measurement
Spheroid growth was monitored by measuring the increase of
the multicellular aggregate diameter over time from brightfield
images, acquired using a Zeiss inverted microscope (Axiovert
A1) with a Labview controlled Dalsa Genie CMOS HM1024
camera. Spheroid dimensions were estimated using ImageJ by
measuring the longest and shortest diameters (D1 and D2,
respectively). These values were then used to calculate the
approximated volume (V) of each spheroid, estimated as
V ¼
4
3
π
D1
2
D2
2
 2
. A comparison analysis between the results
from spheroid irradiation and control experiments (no
irradiation) was performed calculating the area under the
curve V(t )/V0 (where V(t ) is the spheroid volume measured at
each time point and V0 is its initial volume) for each spheroid.
The Mann Whitney and Kruskal Wallis tests were used to
evaluate the statistical diﬀerence between experiments (signifi-
cant diﬀerence between groups obtained for p value ≤0.05).
2.4 Sectioning and staining of spheroids
Approximately 50 spheroids were collected for each manual
droplet-based (3 devices/experiment) and spinner flask experi-
ments and fixed in 10% formalin for a minimum of 12 hours.
Once fixed, the spheroids were tissue-processed before embed-
ding them within a wax block. Blocks containing spheroids
were then sectioned using a microtome (Leica RM2125RTE) to
form 4 μm thick sections which were mounted on polysine
coated slides ready for staining.
For haematoxylin and eosin staining, the sections were first
de-waxed in histoclear (National Diagnostics) and re-hydrated
by successive immersions in 100% (v/v) ethanol,
70% (v/v) ethanol and water. The staining procedure involved
immersions in haematoxylin for 7 min, 1% (v/v) acid alcohol,
Scotts tap water and eosin with intermediate washes in water. The
stained sections were then dehydrated in 70% (v/v) and 100% (v/
v) ethanol and immersed in histoclear before applying mounting
media (Histomount, National Diagnostics) and a coverslip.
2.5. Viability staining of spheroids
Live spheroids from droplet-based experiments were stained for
viability using fluorescein diacetate (FDA) and propidium iodide
(PI) (Sigma Aldrich). Although spheroids could be stained within
emulsions, for ease of procedure, these were typically extracted
from the droplets and washed with phosphate buﬀered saline
(PBS). Spheroids were then incubated with staining solution con-
taining 20 µg ml−1 of PI and 8 µg ml−1 of FDA for approximately
20 minutes. The staining solution was then washed oﬀ and
replaced with PBS before imaging.
2.6. Spheroid irradiation
Spheroids were allowed to form and cultured in M/O droplets
and irradiated with either a single dose of 4 Gy or 8 Gy using a
PXI X-Rad 225C X-irradiator with the dose rate per min equat-
ing to 2.2 Gy per min (RPS Services, Surrey, UK). Subsequently,
both control and irradiated spheroids were cultured and their
size monitored for up to 28 days.
3. Results
Experiments were carried out firstly to characterise the for-
mation and long-term culture of multicellular spheroids in
emulsion-based systems. The utility of the system for analysis
of irradiation on spheroid growth was then examined by
interrogation of the eﬀect of X-ray irradiation (as a model treat-
ment) on single spheroids encapsulated in M/O droplets.
Results were compared to those obtained by similarly treated
spheroids but cultured in low attachment well plates. Finally,
the scalability and miniaturisation of the developed pro-
cedures were tested using a microfluidic system.
3.1. Formation of spheroids in M/O droplets
Droplets containing a specific concentration of cells in suspen-
sion were dispensed in a well previously filled with an oil–surfac-
tant mixture using a pipette. As the oil phase was denser than
the aqueous phase, the droplet floated at the top of the oil layer
within the well, forming a spherical/ellipsoidal medium–oil
interface (Fig. 1). Due to the biocompatible and non-adherent
nature of polyethylglycol-surfactants used, the water–oil interface
was inert and provided an appropriate condition for cell aggrega-
tion. Immediately after dispensing, cells sedimented to the
bottom of the droplet at the oil–surfactant–medium interface.
Cells aggregated within the first 12–24 hours to form a flat
layer of cells (Fig. 1, day 1) at the bottom of the droplet. Pro-
gressively, from day 2 onwards, the cell aggregate structures
became more tightly packed with cells clustering on top
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of each other until formation of a dense, almost spherical
structure (Fig. 1, day 5). The time that was required for the cel-
lular aggregates to form a compact structure depended criti-
cally upon the initial cell concentration used. No significant
diﬀerence in the formation process was observed for spheroids
with a size ranging from 10s to 100s of μm in diameter.
3.2. Investigation of the parameters determining spheroid
growth in M/O droplets
A range of droplet volumes (25–100 μl), encapsulating cell sus-
pensions of diﬀerent concentrations, were tested to determine
the eﬀect on spheroid formation and long-term culture due to
the finite volume of medium present within the droplets, a
condition that is expected to limit the total amount of nutri-
ents inside a droplet and the diﬀusion of cell waste products.
Spheroid growth was monitored over time, without media
replenishment, using brightfield microscopy to estimate the
time period within which no apparent detrimental signs or
growth inhibition were observed, identified as: (1) the time
point, TD, at which spheroid disaggregation was detected,
defined as the condition where the first cell debris were
observed around the spherical compact spheroid structure
(arrows in Fig. 2B); (2) the period of time, TG, over which
spheroid growth plateaued without disaggregation (Fig. 3).
Cells which disaggregated from a compact spheroid were no
longer viable as confirmed by live/dead staining (Fig. S1†).
An approximated exponential relationship between the
number of encapsulated cells per droplet volume (cells per µl)
and TD was identified (Fig. 2). As expected, without medium
exchange, spheroids remained longer in a compact aggregated
structure for progressively larger droplet volumes. In addition,
even though the devices were stored in a humidified environ-
Fig. 1 Formation of multicellular spheroids within M/O droplets. (A&B)
Schematic diagrams showing the principle of formation of a multicellu-
lar spheroid (A side view, B top view). Over time, a cell suspension within
a M/O droplet aggregates into a 3D compact structure. (C) Representa-
tive time lapse sequence of brightﬁeld images (top view) during spheroid
formation within a 100 μL M/O droplet. Scale bar is 300 μm (scale bar is
relative to image size after cropping).
Fig. 2 Assessment of integrity of spheroids by visual inspection. The
scatter plot shows the ratio of ‘cell-number to volume-of-medium’
within the droplet (cells per μl) over the number of days (TD) that the
spheroid remained intact. (A) Brightﬁeld image of an intact spheroid and
(B) brightﬁeld image of a spheroid that shows early signs of loss of
integrity (arrows indicate spheroid disaggregation). Scale bar is 450 μm.
Fig. 3 Inﬂuence of medium exchange on spheroid viability. (A) Bar
chart showing the average volume of spheroids formed within M/O dro-
plets over 28 days, with error bars representing standard error of the
mean. Patterned bars indicate spheroids in droplets where medium was
exchanged from day 15 (as indicated by the arrow). (B) Time lapse of
representative brightﬁeld images of spheroids with medium refreshed
after 15 days. (C) Time lapse of representative brightﬁeld images of
spheroids where medium was never refreshed after seeding an initial
cell suspension. Scale bar is 500 μm.
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ment within the incubator, it was observed that the droplet
volume reduced over time due to evaporation, resulting poten-
tially in a diﬀerence in the concentrations of salts and pH
within the encapsulated medium.
To further investigate the condition of spheroids within drop-
lets during culture when no medium was exchanged, spheroids
were formed with a ratio of approximately 500 cells per μl (fol-
lowing the trend identified in Fig. 2, estimated TD ∼ 10 days). In
this case, it was observed that the change in spheroid size was
negligible between approximately 7 and 11 days after seeding
(TG ∼ 4 days in Fig. 3A), with the first signs of disaggregation
observed for some spheroids on day 9. Before day 7 the cellular
aggregates had not yet reached a compact spheroid-like struc-
ture, as describe in Fig. 1. On day 14 of culture, a considerable
amount of cells were observed to have detached from the
spheroids (Fig. 3B and C) and the integrity of the 3D cellular
structure became increasingly compromised. Finally, to deter-
mine whether the cells within the compact spheroid structure
could proliferate after being in this compromised state, an
experiment was performed where medium was refreshed on day
15 for half of the spheroids in the same device (with medium
exchanged every two days), while the remaining half was kept in
the same unchanged condition. Only in the case of medium
exchange did the spheroids increase in size (Fig. 3A and day 28
in Fig. 3B), while the remaining ones continued to lose integrity,
accumulating an increasing amount of cell debris within the
droplet (Fig. 3A and day 28 in Fig. 3C).
3.3. Determination of impact of droplet culture on
uniformity of spheroid size
Having established the eﬀect of medium refreshment on
spheroid growth within droplets, the uniformity in spheroid
size and growth rate was investigated for variable initial cell
seeding concentrations. In this instance, medium was refreshed
in each droplet every two days by exchanging approximately
50% of the droplet content. Spheroid growth was monitored
over 18 days, with the first significant measurement being the
one at which the cell aggregate reached a minimum size after
seeding (due to the cell aggregating process – as described in
section 3.1). A cell number of either 500 cells or 1500 cells into
medium were dispensed when forming droplets of 100 μl,
leading to formation of spheroids with an initial diameter of
∼300 μm (∼day 3 after seeding) and ∼575 μm (∼day 6 after
seeding), respectively. Two growth patterns were identified with
the smallest size spheroids presenting a faster growth rate
(∼50% increase in diameter over initial value) in the first 8 days
of culture in comparison to the larger spheroids (∼25% increase
in diameter over initial value). Following this period, in both
cases the growth rate of the spheroids was approximately 6 μm
per day of increase in diameter (Fig. 4).
3.4. Investigation of spheroid morphology
To investigate any morphological diﬀerences between spher-
oids formed using the proposed M/O droplet technique and
those obtained from conventional spinner flask techniques,
spheroid sections were prepared, stained and analysed to
determine changes in spheroid architecture and organisation.
Spheroids of comparable size and days of culture from both
techniques, ranging from 300 μm (5 days culture) to 750 μm
(18–21 days culture) in diameter, were compared (Fig. 5).
Spheroids formed after 5 days of culture from either droplets
or spinner flasks, presented similar characteristics in term of
cell packing, internal cohesion and nuclei size (Fig. 5A and C).
A considerable diﬀerence was instead identified between the
two families of spheroids only for cells at their outer layers,
where spheroids from spinner flasks lacked a smooth and
compact border (Fig. 5B and D).
For larger spheroids, a morphological diﬀerence was
observed compared to the smaller ones, as two distinct areas
within the stained sections were identified (Fig. 5E and H): cells
in the outer layer were more tightly packed than within the core.
As a consequence, the cell nuclei in the core were more spherical
than those in the outer rim, as also previously reported by Rajce-
vic et al. who observed the tight packing of cells within the
spheroid and diﬀerence in shape of nuclei as a result.29
3.5. Comparison of irradiation eﬀects on spheroid growth
parameters
The toxicity induced by X-ray irradiations on spheroids of
similar size (average diameter ∼450 μm) obtained from dro-
plets and spinner flasks was compared (although spheroid size
variability using a spinner flask was higher than with those
Fig. 4 Control of spheroid size in M/O droplets. (A) Line graphs
showing spheroids with diﬀerent initial diameters ranging from
275–340 μm (termed ‘small spheroids’) to 530–600 μm (termed ‘large
spheroids’). Error bars indicate the standard error of the mean and n =
15 for each experiment. (B&C) Representative brightﬁeld time-lapse
images of small spheroids (top row) and large spheroids (bottom row).
Scale bar is 350 μm.
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formed in droplets). Spheroids were typically treated with 8 Gy
of radiation on day 7 of culture. In comparison to non-
irradiated control spheroids, irradiation with 8 Gy induced a
significant reduction in their growth when formed both within
droplets (p < 0.01) and within a non-adherent plate (p < 0.0001)
(Fig. 6). Live/dead cell staining showed, qualitatively, that
Fig. 5 Haematoxylin and eosin staining of spheroid sections. Images of
sections from a small (∼300 µm) spheroid grown in a droplet, (A) and
(B), and derived from a spinner ﬂask, (C) and (D). Images of sections
from a large spheroid (∼750 µm) from a droplet, (E), (F) and (G), and
derived from a spinner ﬂask, (H), (J) and (K). Scale bar in (A) & (C) is
150 μm; in (B) & (D) is 75 μm; in (E) & (H) is 400 μm and in (F), (G), (J) and
(K) is 200 μm.
Fig. 6 Eﬀect of radiation treatment on spheroid growth. (A) Line graphs
showing the average volume ± standard error of the mean for spheroids
formed from a spinner ﬂask versus those formed within droplets. In both
cases, spheroids were treated with a single dose of 8 Gy on day 7 of
culture with 0 Gy representing controls (the arrow indicates the day of
irradiation). (n = 15 for each experiment). (B&C) Bar charts showing the
average volume ± standard error of the mean for spheroids formed
within droplets one week after treatment with each bar representing a
separate experiment (n = 15). Comparable eﬀects were produced by 4
Gy and 8 Gy doses of radiation on small spheroids (275–340 μm dia-
meter) (A) and large spheroids (530–600 μm diameter) (B). * represents
a p value ≤0.05 and **** a p value ≤0.0001.
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irradiation eﬀects progressively induced cell death over time
with respect to the control, with a considerable decrease in
spheroid size (Fig. S2†). No significant diﬀerence in the growth
of spheroid before and after radiation was observed that was
dependent on the technique used for spheroid formation and
culture. A further experiment was carried out to determine the
eﬀect on spheroid growth following exposure to two diﬀerent
doses of radiation (4 Gy and 8 Gy) on spheroids of diﬀerent size
ranges (Fig. 6B and C). A dose of 8 Gy induced a significant
reduction in size for both large and small spheroids compared to
the control (p < 0.0001 for each experiment), leading to a volume
diﬀerence of −44% for small spheroids and −55% for large
spheroids. Conversely, 4 Gy irradiation induced little or no sig-
nificant growth perturbation with respect to the control group.
To identify whether spheroids in a ‘dormant’ state were
more radioresistant than those in a proliferative state, radi-
ation experiments were carried out with spheroids in droplets
where medium was either exchanged regularly from the start
of the culture or was not exchanged until the day of
irradiation. To determine when the dormant state had been
induced, spheroid size was monitored until the first signs of
cell detachment were observed (TD = 16 days in this experi-
ment) and live/dead cell staining performed, correlating spher-
oid growth with cell viability (Fig. S1 and S2 in ESI†). After
irradiation, medium was regularly refreshed as per the control
experiments. To ensure that control spheroids were in a proli-
ferative state, these were irradiated on day 7 of culture (accord-
ing to results in Fig. 2A). The spheroids in both conditions
were treated with radiation when they were of a similar size. To
assess the response between the two cases, the percentage
diﬀerence of the average spheroid volume after treatment with
8 Gy with respect to their size before irradiation was plotted
(Fig. 7). In addition, with respect to the case of spheroids
having media being regularly refreshed, live/dead cell staining
showed, qualitatively, a reduced eﬃcacy of irradiation both on
spheroid growth and death when those were kept in a less
thriving environment (Fig. S2†).
A one way ANOVA test was carried out to identify diﬀerences
between the percentage volume change on day 4 post
irradiation treatment between the control and irradiated
groups. A significant diﬀerence was observed between spher-
oids which were refreshed and those which were not (p <
0.0001 between dashed lines in Fig. 7). The results show that
irradiation had a more significant impact on reducing the
spheroid size when the multicellular aggregates were in a
nutrient rich environment than when in a dormant condition
where medium had not been refreshed (as previously shown in
Fig. 3, after medium was refreshed in droplets containing
control dormant spheroids, these quickly recovered their
growth). In both cases, the comparison between control
and radiation experiments (for both medium exchange and
no medium exchange) produces a significant diﬀerence
(p < 0.0001 for each experiment), suggesting that the radiation
impacts spheroid growth regardless of their proliferative
status. In addition, the spheroids grown in a low nutrient
environment were observed to grow at a faster rate when
replenished with medium in comparison to those with con-
stant refreshment (p < 0.0001). This suggests that, compared
to nutrient-rich cells, dormant cells were not only more resist-
ant to radiation, but also exhibited a more aggressive pheno-
type upon re-exposure to nutrients.
3.6. Assay scalability using droplet microfluidics
Preliminary experiments were performed using droplet micro-
fluidics to investigate the miniaturisation and scalability
opportunities of the presented emulsion technology for devel-
oping spheroid-based assays. The device structure was based
on the design by Schmitz et al.,28 containing a chamber array
that allows for the trapping and storage of M/O droplets encap-
sulating cells. Droplets were produced via a T-junction geome-
try and then stored within an array of 2128 chambers (Fig. 8).
The microfluidic structure allows droplets to remain trapped
in the round-shaped microchannels within the chamber,30
each droplet being separated from one another by a layer of oil
to prevent coalescence and facilitate long-term storage. Typi-
cally, the droplet trapping eﬃciency was ∼68%, with the per-
centage of droplets containing multiple cells varying from
60% to 95% depending on the cell concentration used. Once
multiple cells were encapsulated within droplets, the aggrega-
tion process occurred as in the macroscopic droplets forming
compact spheroids within 12–24 hours depending upon the
initial cell number within the droplet. However, due to the
current structure of the device, the medium within the droplets
could not be refreshed. Consequently, the lifetime of the spher-
oids was 3–4 days, according to the trend identified in Fig. 2.
Fig. 7 Eﬀect of medium exchange on spheroid response to 8 Gy radi-
ation treatment. Representative line graphs show the percentage diﬀer-
ence of spheroid volume after treatment with respect to their size
before irradiation, with error bars representing the standard error of the
mean. A comparison is shown between experiments where medium was
regularly refreshed every 2 days (control spheroids (0 Gy) and radiated
spheroids) and where medium was refreshed only after radiation on day
16 of culture (control spheroids and radiated spheroids). The arrows in
the graph indicate the day at which the spheroids were treated with
8 Gy of radiation.
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4. Discussion
Multicellular tumour spheroids could be formed within M/O
droplets and the time taken for cell to aggregate from a flat
monolayer to an ellipsoidal 3D structure depended upon the
initial cell number encapsulated in the droplet. This is consist-
ent with previous reports where spheroids have been formed
using double emulsion techniques14 or microcapsules.20
However, in contrast to previous publications, we used single
emulsions and identified the parameters that allow us to
culture spheroids over a long period of time. Furthermore, we
have capitalized on emulsion compartmentalization for the
creation of in vitro tumour quiescent models.
The compartmentalised aspects of the proposed emulsion-
based system are similar to those obtained in a hanging
droplet system.32 However, M/O droplets have the advantage of
being unaﬀected by vibration, mechanical shocks or tilting of
the plate. These issues are known to compromise the stability
of water-in-air droplets hanging from the plastic anchor sites,
which ultimately result in droplet detachment from the plate.
The robustness to handling and transporting M/O droplet
plates derives from the support that the denser oil layer pro-
vides to the floating (water-based) droplets and the interfacial
tension properties of the phases. These allow spheroid con-
taining droplets to easily move within the well, without com-
promising spheroid integrity and the emulsion interface
stability, even when transporting the device.
Spheroids from M/O droplets had a similar morphology
and phenotypic characteristics to those produced using tra-
ditional methods (i.e. spinner flask and low adhesion plates).
As consistently reported in the literature, with a progressive
increase in the spheroid size, gradients of nutrients and
oxygen are formed from the outside to the core of the 3D mul-
ticellular structure, a condition that aﬀects growth rate, cell
proliferation and spheroid size. As apparent from the sections
(Fig. 5), spheroids grown to a diameter larger than 500 μm pres-
ented a clear diﬀerence between the inner and outer layers.8
The outer cells presented more oblong shaped nuclei than
those in the core of the spheroid which were more spherical in
shape, suggesting a diﬀerence in the packing of cells. The
growth curve of the spheroids formed in M/O droplets showed
a similar trend to those of UVW cell spheroids by Neshasteh-
Riz et al. (1997)33 where forced floating methods were used.
A reduction in the growth rate over time is expected when a
spheroid increases in size, as it becomes denser due to the
higher cell number and a higher proportion of cells within the
spheroid are starved of the nutrients necessary for division.12
An important factor which was considered in this study was
to identify the conditions required for the long term culture of
spheroids within droplets, as cancer assays may be required to
be conducted for up to 4 weeks in order to determine whether
a treatment is cytostatic or cytotoxic and to be comparable
with in vivo studies.34–36 Any compartmentalised environment
is naturally associated with a limited amount of nutrient
(which aﬀects the temporal availability of resources) and also
with accumulation of waste product (due to the cell metabolic
activity). Within a finite volume of medium, the proliferating
cells in the outer layer of the spheroid will be exposed to pro-
gressively less nutrients and more toxic metabolites, greatly
aﬀecting their condition and inducing first a dormant state,
followed by increased cell death and disaggregation. Tumour
cells are known to consume a high amount of glucose, in
order to produce ATP and to meet the requirements for pro-
liferation.37 In contrast to normal cells, which rely upon oxi-
dative phosphorylation to provide the products required for
proliferation, when tumour cells undergo proliferation they
carry out glycolysis.37,38 Glycolysis is advantageous to highly
proliferative cells as it results in a higher rate of glucose pro-
duction in comparison to oxidative phosphorylation.39 Fur-
thermore, the breakdown of glucose for harvesting energy also
produces products required for the synthesis of essential bio-
molecules such as lipids, amino acids and nucleotides.38
When there is a reduction in the availability of glucose, such
as the environment created when medium is not refreshed in
a droplet, the cells undergo a transition into a quiescent state
for a period of time and, if no extra nutrients are provided,
they will then undergo apoptosis.38 The high consumption of
nutrients required for tumour cell proliferation means that
compartmentalisation is an important factor to consider when
developing encapsulation based technologies for long term
spheroid culture. However, optimum exchange rate of medium
Fig. 8 Microﬂuidic device for the high-throughput formation and
storage of multicellular spheroids. (A) Diagram of the microﬂuidic device
with an array chamber containing over 2000 droplet sites. (B) Schematic
diagram of droplet formation and cell encapsulation. (C) and (D)
Brightﬁeld images of cells encapsulated within droplets and trapped
within the storage array on day 0 and day 1 after culture. Cells aggre-
gated to form spheroids after 24 hours. Scale bar for (C) is 115 μm and
for (D) is 230 μm.
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would depend on the metabolic activity of the cancer cell type
under investigation.
In other studies involving miniaturisation and the encapsu-
lation of cells within microdroplets, beads or microcapsules,
the duration of cell incubation varied between as little as 2
days to up to 12 days14–18,20,40 and cell viability in droplets was
reduced over hours rather than days or weeks.14–20,31 The
ability to extend the temporal duration of the assay whilst con-
trolling the spheroid size and its proliferation/quiescent state
can be useful for mimicking diﬀerent tumour condition (i.e.
relapse) when investigating the eﬃcacy of a treatment and the
limitations with therapy screening assays.36 Additionally, the
use of single emulsions rather than double emulsions facili-
tates operational procedures.
Quiescent cells are known to be more radioresistant than
cells in a proliferative state.5,41–44 Results from this study
showed that there was less irradiation-induced toxicity in
quiescent cells in comparison to proliferative cells. From other
studies it has been hypothesized that the quiescent cells have
a greater ability with respect to proliferating cells to initiate
repair of potentially lethal damage (such as those caused to
DNA by radiation41) and these mechanisms could be respon-
sible for the observed diﬀerences in radiation-induced toxicity.
Emulsion-based systems allows for these characteristics to be
investigated and applied to both radiotherapy and chemo-
therapy. However, in the case of chemotherapy, drugs can par-
tition into the oil phase depending on their degree of
solubility.45 This represents a limitation with the described
emulsion methodology which can nonetheless be solved via
calibration and implementation of a perfusion system.
The use of M/O droplet system for radiotherapeutic assays
was tested on UVW glioma cell line as these are known to be
radioresistant. Boyd et al. (2000)27 have previously demon-
strated that UVW cells, grown as a monolayer, were moderately
resistant to irradiation with approximately 56% cells surviving
after delivery of a 2 Gy dose. Therefore, it is expected that due
to the variation in cell proliferation rates, hypoxia and the pro-
portion of non-proliferating cells in larger 3D spheroids, the
radiation dose required to inhibit growth would be larger. This
was confirmed in these studies, as for spheroids ranging from
300 to 700 µm in diameter, a dose of 4 Gy had little if no sig-
nificant eﬀect on spheroid growth in the short term after
irradiation (Fig. 7). Conversely, a dose of 8 Gy induced approxi-
mately a 50% reduction in spheroid size one week after
treatment.
Finally, proof of concept data with our microfluidic experi-
ments demonstrates the potential of emulsion based tech-
niques to be used for high-throughput screening assays. In
comparison to hanging drop plates where the highest number
of drops per device is currently limited to 384, miniaturisation
of emulsion control in microfluidics oﬀers a much higher
throughput (1276 spheroids were formed per device in our pro-
totypes). Further work is currently undergoing in our labs to
implement regular medium exchange in the microfluidic plat-
form, this condition being necessary to extend the lifetime
and the functionality of the miniaturised assay.
5. Conclusion
In this work, we have characterised the use of emulsion tech-
nology for the development of assays based on multicellular
tumour spheroids, investigating the key parameters that
enable controlled spheroid formation and the conditions that
support long-term culture. We have characterised the con-
ditions that allow us to control the level of cell proliferation
and quiescence in a multicellular tumour spheroid and used
this in establishing the eﬀect induced by radiotherapy on
spheroid growth according to their size and irradiation dose.
Furthermore, preliminary experiments have been conducted
using droplet microfluidic techniques to demonstrate the
feasibility of scaling spheroid based assays to a high through-
put format. The implementation of medium perfusion in such
a miniaturised platform has potential to open the way to large-
scale testing of combination therapeutics and use with biopsy
samples.
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SUPPLEMENTARY FIGURE 1
Figure S1. Assessment of cell detachment from spheroid using live/dead staining. (A) 
Brightfield image and (B) fluorescent image of a spheroid stained with fluorescein diacetate 
(green) (viable) and propidium iodide (red) (non-viable) within a M/O droplet. Media inside 
the droplet was not refreshed for 18 days. The arrows indicate cells which have 
disaggregated from the spheroid, all of which are not viable. Scale bar = 150 µm. 
(OHFWURQLF 6XSSOHPHQWDU\ 0DWHULDO (6,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2SUPPLEMENTARY FIGURE 2
Figure S2. Representative images showing the influence of medium exchange and radiation 
treatment on spheroid viability. Fluorescent images of spheroids stained with fluorescein 
diacetate (green) (viable) and propidium iodide (red) (non-viable). The top and bottom rows 
show spheroids which had their medium refreshed every 2 days from the start of culture and 
the second and third row shows spheroids which had no medium refreshment until day 18. 
The bottom row shows a spheroid treated with 8Gy of radiation on day 7 while the third row 
shows a spheroid treated with 8Gy on day 18 (day 18 representing a time point at which the 
spheroid growth had plateaued due to no medium exchange). The spheroid for day 3 
represents an early stage culture spheroid which has not yet developed a necrotic core and 
is representative for all the cases above.
